WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-15.16%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$1.4B
AUM Growth
-$1.05B
(-43%)
Cap. Flow
-$794M
Cap. Flow
% of AUM
-56.72%
Top 10 Holdings %
Top 10 Hldgs %
29.68%
Holding
181
New
76
Increased
18
Reduced
42
Closed
45
Top Buys
| 1 |
Pfizer
PFE
|
$65.7M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$46.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$46.5M |
| 4 |
Applied Materials
AMAT
|
$45.4M |
| 5 |
Analog Devices
ADI
|
$27.8M |
Top Sells
| 1 |
Texas Instruments
TXN
|
$69.5M |
| 2 |
NVIDIA
NVDA
|
$64.1M |
| 3 |
Meta Platforms (Facebook)
META
|
$63M |
| 4 |
ASML
ASML
|
$60M |
| 5 |
Gilead Sciences
GILD
|
$55.1M |
Sector Composition
| 1 | Healthcare | 45.77% |
| 2 | Technology | 31.94% |
| 3 | Communication Services | 11.27% |
| 4 | Consumer Discretionary | 2.11% |
| 5 | Industrials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
F5
FFIV
$18.1B
| $1.05M | 0.08% |
9,875
-215,997
| -96% | -$23M |
|
|
HARP
127
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $914K | 0.07% |
+7,894
| New | +$914K |
|
|
128
NVIDIA
NVDA
$4.07T
| $846K | 0.06% |
128,440
-9,734,960
| -99% | -$64.1M |
|
|
LGF.A
129
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $773K | 0.06% |
+127,081
| New | +$773K |
|
|
AFMD
130
DELISTED
Affimed
AFMD
| $746K | 0.05% |
+47,204
| New | +$746K |
|
|
TECD
131
DELISTED
Tech Data Corp
TECD
| $746K | 0.05% |
+5,702
| New | +$746K |
|
132
Savara
SVRA
$643M
| $740K | 0.05% |
+348,946
| New | +$740K |
|
133
Sensata Technologies
ST
$4.66B
| $550K | 0.04% |
19,023
-624,534
| -97% | -$18.1M |
|
134
Microchip Technology
MCHP
$35.6B
| $474K | 0.03% |
13,994
-1,208,594
| -99% | -$40.9M |
|
|
APTO
135
DELISTED
Aptose Biosciences, Inc.
APTO
| $327K | 0.02% |
+122
| New | +$327K |
|
136
TELA Bio
TELA
$63M
| $315K | 0.02% |
40,238
-188,296
| -82% | -$1.47M |
|
137
Teradyne
TER
$19.1B
| – | – |
-432,292
| Closed | -$29.5M |
|
138
TSMC
TSM
$1.26T
| – | – |
-750,196
| Closed | -$43.6M |
|
139
Travere Therapeutics
TVTX
$1.93B
| – | – |
-281,423
| Closed | -$4M |
|
|
140
Texas Instruments
TXN
$171B
| – | – |
-541,969
| Closed | -$69.5M |
|
141
Dentsply Sirona
XRAY
$2.92B
| – | – |
-398,922
| Closed | -$22.6M |
|
142
Amgen
AMGN
$153B
| – | – |
-124,090
| Closed | -$29.9M |
|
|
143
ASML
ASML
$307B
| – | – |
-202,674
| Closed | -$60M |
|
144
Ascendis Pharma
ASND
$12.5B
| – | – |
-55,284
| Closed | -$7.69M |
|
145
Altice USA
ATUS
$1.05B
| – | – |
-854,406
| Closed | -$23.4M |
|
146
Avantor
AVTR
$9.07B
| – | – |
-615,127
| Closed | -$11.2M |
|
147
Booking.com
BKNG
$178B
| – | – |
-8,124
| Closed | -$16.7M |
|
148
Bristol-Myers Squibb
BMY
$96B
| – | – |
-552,945
| Closed | -$35.5M |
|
149
Boston Scientific
BSX
$159B
| – | – |
-832,550
| Closed | -$37.6M |
|
150
Cigna
CI
$81.5B
| – | – |
-106,097
| Closed | -$21.7M |
|